登记Id

PA164740891

药物名称(英)

zanamivir

通用名称

"GANA","GNA","Modified sialic acid","ZMR","Zanamavir"

商品名称

Relenza

品牌组合

类型(英)

Drug

类型

药品

交叉引用

"BindingDB:4934","Canadian Drugs Product Database:02240863","ChEBI:CHEBI:50663","Chemical Abstracts Service:139110-80-8","ChemSpider:54842","DrugBank:DB00558","FDA Drug Label at DailyMed:d7c3bcc3-0c0d-4068-fd80-88cf54a376ef","HET:ZMR","KEGG Compound:C08095","KEGG Drug:D00902","National Drug Code Directory:0173-0681-01","PDB:ZMR","PubChem Compound:60855","PubChem Substance:197092","PubChem Substance:46508581","Therapeutic Targets Database:DAP000715","URL:http://en.wikipedia.org/wiki/Zanamivir"

简化分子线性输入规范

CC(=O)N[C@@H]1[C@H](C=C(O[C@H]1[C@@H]([C@@H](CO)O)O)C(=O)O)N=C(N)N

键

InChI=1S/C12H20N4O7/c1-4(18)15-8-5(16-12(13)14)2-7(11(21)22)23-10(8)9(20)6(19)3-17/h2,5-6,8-10,17,19-20H,3H2,1H3,(H,15,18)(H,21,22)(H4,13,14,16)/t5-,6+,8+,9+,10+/m0/s1

剂量指南

No

外部词汇

"ATC:J05AH01(zanamivir)","UMLS:C0216660(Zanamivir)","RxNorm:69722(Zanamivir)","NDFRT:N0000148618(ZANAMIVIR)"

RxNorm 标识符

69722

ATC 标识符

J05AH01

化合物标识符

60855